Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Jun
29
2018
Recreational Marijuana in Massachusetts: What Should Employers Know? Epstein Becker & Green, P.C.
Sep
14
2021
Marijuana Legalization Rundown: Recent Judicial Decisions Epstein Becker & Green, P.C.
Oct
16
2018
New Draft Guidance on Adaptive Designs for Clinical Trials Epstein Becker & Green, P.C.
Nov
26
2018
Can I Bring Cannabis from Canada Home? Epstein Becker & Green, P.C.
Mar
1
2022
Unpacking Averages: Connecting Published Clinical Trials with FDA Drug Approvals Epstein Becker & Green, P.C.
May
16
2019
FDA Declines to Ban Breast Implants, Will Require Full MDR Reporting by Manufacturers Epstein Becker & Green, P.C.
Jun
18
2019
Employer Insights: Recreational Marijuana in Illinois Epstein Becker & Green, P.C.
Aug
26
2022
Will the Supreme Court’s Latest Decision on Mens Rea Leave Medical Professional Prosecutions Ruan-ing on Empty? Epstein Becker & Green, P.C.
Aug
22
2019
New York State Decriminalizes Possession of Marijuana Epstein Becker & Green, P.C.
Aug
13
2015
Telehealth / Remote Care 2.0: The Coming Disruption Epstein Becker & Green, P.C.
Feb
9
2023
Podcast: Unpacking FDA’s Final Clinical Decision Support Guidance – Diagnosing Health Care [VIDEO] Epstein Becker & Green, P.C.
Mar
3
2023
FDA Issues Draft Guidance on Labeling of Plant-Based Milk Alternatives Epstein Becker & Green, P.C.
Mar
19
2020
FDA Issues Guidance for Ongoing Clinical Trials During COVID-19 Pandemic Epstein Becker & Green, P.C.
Apr
28
2020
Face or Fingerprint? The DEA Revisits Biometric Identifiers for e-Prescribing Controlled Substances Epstein Becker & Green, P.C.
Jan
3
2024
Unpacking Averages: The Seasonality of FDA 510(k) Decision-Making and the Impact of Michigan Playing for a National Championship Epstein Becker & Green, P.C.
Apr
2
2024
Unpacking Averages: Adverse Events for Device-Lead Combination Products Epstein Becker & Green, P.C.
Nov
1
2021
Unpacking Averages: Analyzing Descriptions from Cardiovascular Device Adverse Events Epstein Becker & Green, P.C.
Dec
1
2021
Unpacking Averages: Popular Ways to Combine Device Functionality Epstein Becker & Green, P.C.
Apr
3
2019
FDA Commissioner Gottlieb Says Agency Will Not Tolerate Deceptive Marketing of CBD Products; Issues Warning Letters Epstein Becker & Green, P.C.
Jul
16
2022
FDA Greenlights Pharmacists to Prescribe COVID-19 Drug Paxlovid Epstein Becker & Green, P.C.
Nov
22
2019
Limitations on Pre-Employment Testing for Marijuana Epstein Becker & Green, P.C.
Feb
2
2016
FDA Recommends Medical Device Manufacturers Implement a Comprehensive Cybersecurity Risk Management Program in Accordance with NIST Standards Epstein Becker & Green, P.C.
Jul
11
2023
Unpacking Averages: Searching for Bias in Word Embeddings Trained on FDA Regulatory Documents Epstein Becker & Green, P.C.
Mar
24
2020
Medical Marijuana Deemed “Essential” During COVID-19 Pandemic Epstein Becker & Green, P.C.
Oct
24
2023
Congress May Have a Vision for Psychedelic Regulation in the US Epstein Becker & Green, P.C.
Jan
10
2017
New Federal and State Initiatives Seek to Combat Antimicrobial Resistance Epstein Becker & Green, P.C.
Jun
7
2017
Growing Questions About Employee Medical Marijuana Use Leave Employers in a Haze Epstein Becker & Green, P.C.
Nov
1
2021
New York DOL Issues FAQs on Recreational Cannabis – Guidance for Employers Epstein Becker & Green, P.C.
Oct
23
2018
CMS Unveils Proposed Rule Regarding Direct-to-Consumer Television Advertisements for Prescription Drug and Biological Products Epstein Becker & Green, P.C.
Dec
18
2018
Mixed Results for Employers on Marijuana – Two Federal Courts Refuse to Find State Marijuana Laws Preempted by Federal Law Epstein Becker & Green, P.C.
Aug
29
2019
Will the Growing Acceptance of Cannabis Send Drug-Screening Policies Up in Smoke? Epstein Becker & Green, P.C.
Feb
7
2024
NJ Approves Cannabis Regulatory Amendment with Major Impacts on Class 5 Retail License Holders Epstein Becker & Green, P.C.
Mar
26
2024
Court Clarifies Employers’ Rights Under Connecticut’s Palliative Use of Marijuana Act, Guidance on Drug Testing Epstein Becker & Green, P.C.
Apr
11
2024
FDA Releases Draft Guidance on New Dietary Ingredient Notification Master Files for Dietary Supplements Epstein Becker & Green, P.C.
Feb
13
2019
CBD “Edibles” Face Opposition from States, FDA Epstein Becker & Green, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins